Coronavirus (COVID-19) Support Resource Center
Are you paying sky-high prices for Copaxone? Keller Rohrback wants to hear your story.

Are you paying sky-high prices for Copaxone? Keller Rohrback wants to hear your story.

Teva Pharmaceutical Industries (“Teva”), the maker of the multiple sclerosis drug Copaxone, allegedly boosted the drug’s price tag from $17,000 to $73,000 per year—turning an already pricy medication into a completely inaccessible one for many. If you’re concerned that you’ve been paying too much for Copaxone, Keller Rohrback wants to hear from you.

Website Design by 3Circle Media